Infection risks in multiple myeloma: a systematic review and meta-analysis of randomized trials from 2015 to 2019

Clicks: 104
ID: 269371
2021
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #38 of 44 articles by views in BMC cancer

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
This is the first study to quantify the monthly risk of grade III or higher infection, pneumonia, and neutropenia across different treatment regimens in the frontline, maintenance, and relapsed/refractory settings. The results of our systematic review demonstrate a significant risk for severe infect …
Reference Key
n2021bmcinfection Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Balmaceda N;Aziz M;Chandrasekar VT;McClune B;Kambhampati S;Shune L;Abdallah AO;Anwer F;Majeed A;Qazilbash M;Ganguly S;McGuirk J;Mohyuddin GR;;
Journal BMC cancer
Year 2021
DOI
DOI not found
URL
https://www.pubmed.gov/34172037/
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE pubmed abstract nih national institutes of health national library of medicine pmid:34172037 pmc8233183 doi:10.1186/s12885-021-08451-x nicole balmaceda muhammad aziz ghulam rehman mohyuddin

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.